Search

everythinglearnresearchcommunity

for

Search:↓

A new painless method to collect hair follicles helps study DNA damage and aging.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with irregular periods have a higher risk of heart disease.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The first Japanese family with Marie Unna hereditary hypotrichosis showed hair condition improvement in a child and highlighted the risk of misdiagnosis.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Researchers concluded that "spigo nardo" is the Himalayan plant Nardostachys jatamansi, used historically in medicine and cosmetics, now critically endangered.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

More knowledge about the risks of performance-enhancing agents leads to less use in north-western Saudi Arabia.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Dutch dermatologists prioritized skin conditions like melanoma and psoriasis for guideline development, focusing on consistent care over cost or death rates.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.